Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2014 | 07-2014 | 04-2014 | 01-2014 | 10-2013 | |
| Sales | 0 | 0 | 1,000 | 0 | 0 |
| Gross Profit | N/A | N/A | 1,000 | N/A | N/A |
| Operating Expenses | 0 | 5,999 | 3,596 | 5,958 | 0 |
| Operating Income | N/A | -5,999 | -2,596 | -5,958 | N/A |
| Interest Expense | 0 | 0 | 3 | 2 | 0 |
| Other Income | 0 | 220 | 285 | 147 | 0 |
| Pre-tax Income | 0 | -5,779 | -2,315 | -5,813 | 0 |
| Income Tax | N/A | N/A | N/A | -626 | N/A |
| Net Income Continuous | N/A | -5,779 | -2,315 | -5,187 | N/A |
| Net Income | $N/A | $-5,779 | $-2,315 | $-5,187 | $N/A |
| EPS Basic Total Ops | N/A | -359.82 | -179.91 | -443.78 | N/A |
| EPS Basic Continuous Ops | N/A | -359.65 | -176.27 | -449.48 | N/A |
| EPS Diluted Total Ops | N/A | -359.82 | -179.91 | -443.78 | N/A |
| EPS Diluted Continuous Ops | N/A | -359.65 | -176.27 | -449.48 | N/A |
| EBITDA(a) | $N/A | $-5,947 | $-2,546 | $-5,909 | $N/A |